Reviva Pharmaceuticals Holdings, Inc. (RVPH) Reports FY24 results
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported FY24 EPS of ($0.90).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
- John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
